Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015436
Filing Date
2024-11-13
Accepted
2024-11-13 07:45:33
Documents
59
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cgtx-20240930x10q.htm   iXBRL 10-Q 1369548
2 EX-31.1 cgtx-20240930xex31d1.htm EX-31.1 16713
3 EX-31.2 cgtx-20240930xex31d2.htm EX-31.2 17002
4 EX-32.1 cgtx-20240930xex32d1.htm EX-32.1 10082
5 EX-32.2 cgtx-20240930xex32d2.htm EX-32.2 10255
  Complete submission text file 0001558370-24-015436.txt   5521660

Data Files

Seq Description Document Type Size
6 EX-101.SCH cgtx-20240930.xsd EX-101.SCH 34843
7 EX-101.CAL cgtx-20240930_cal.xml EX-101.CAL 38794
8 EX-101.DEF cgtx-20240930_def.xml EX-101.DEF 140679
9 EX-101.LAB cgtx-20240930_lab.xml EX-101.LAB 362414
10 EX-101.PRE cgtx-20240930_pre.xml EX-101.PRE 265270
62 EXTRACTED XBRL INSTANCE DOCUMENT cgtx-20240930x10q_htm.xml XML 786817
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40886 | Film No.: 241451223
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)